NCT06218498Status unknown
Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia
Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Erbium-glass Laser for the Treatment of Male Androgenetic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Participants (registry)
- 135
- Start
- November 2023
- Primary completion
- June 2024
- Study completion
- December 2024
- Last registry update
- January 2024
- Countries
- China
Conditions studied: Androgenetic Alopecia
Interventions: ablative fractional 2940-nm Er: YAG laser, non-ablative fractional 1565nm, 5% Minoxidil
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.